P6P2 Intrinsic Valuation and Fundamental Analysis - Replicel Life Sciences Inc

R	Replicel Life Sciences Inc F:P6P2	CA
	Aker Biomarine ASA F:1PG	NO
D	Dynasty Gold Corp OTC:DGDCF	CA

Intrinsic Value

P6P2 price has not been updated for more than 6 months. This may indicate that the stock has been delisted.

P6P2 doesn't have a meaningful market cap.

The intrinsic value for Replicel Life Sciences Inc (P6P2) under the Base Case is 0.0317 EUR. Compared with the current market price of 0.0725 EUR, the stock appears Overvalued by 56% .

Intrinsic value calculated using DCF

€0.0317

Other reference points

Multiples estimate

€0.0942

Do our valuations actually work? See backtest results .

P6P2 Intrinsic Value

Overvaluation 56%

Intrinsic Value

Price €0.0725

Track Buy Zone

20% below Intrinsic Value €0.03

Get notified when the price drops into your buy zone

Current Price €0.07

Intrinsic Value €0.03

Margin of Safety 20% €0.03

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Replicel Life Sciences Inc.

Explain Valuation